this piece corresponds to the legacy myPDB login in the form of a bootstrap modal, will likely retire-->

Chemical Component Summary

NameL-DOPAMINE
Identifiers4-(2-aminoethyl)benzene-1,2-diol
FormulaC8 H11 N O2
Molecular Weight153.18 g/mol
TypeNON-POLYMER
Isomeric SMILESNCCc1ccc(O)c(O)c1
InChIInChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
InChIKeyVYFYYTLLBUKUHU-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count22
Chiral Atom Count0
Chiral Atomsn/a
Bond Count22
Aromatic Bond Count6
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00988 Stereoisomeric match
NameDopamine
Groupsapproved
DescriptionOne of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action. [PubChem]
Synonyms
  • 2-(3,4-Dihydroxyphenyl)ethylamine
  • 3-Hydroxytyramine
  • 3,4-Dihydroxyphenethylamine
  • 4-(2-Aminoethyl)-1,2-benzenediol
  • 4-(2-Aminoethyl)benzene-1,2-diol
SaltsDopamine Hydrochloride
Brand Names
  • Dopamine
  • Dopamine HCl
  • Dopamine HCl Inj 4%
  • Dopamine Hydrochloride
  • Dopamine Hydrochloride and Dextrose
Affected OrganismHumans and other mammals
IndicationFor the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure
PharmacologyDopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine produces positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on beta-adrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings.
Mechanism of actionDopamine is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system. Dopamine produces positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on beta-adrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings. In the brain, dopamine actas as an agonist to the five dopamine receptor subtypes (D!, D2, D3, D4, D5).
Route of administrationIntravenous
Categories
  • Adrenergic and Dopaminergic Agents
  • Alcohols
  • Amines
  • Amino Alcohols
  • Autonomic Agents
ATC-CodeC01CA04
CAS number51-61-6
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682